Drug Shortage Report for BIO-TELMISARTAN
Report ID | 244148 |
Drug Identification Number | 02522926 |
Brand name | BIO-TELMISARTAN |
Common or Proper name | TELMISARTAN |
Company Name | BIOMED PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2024-11-21 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-11-28 | French | Compare |
v1 | 2024-11-28 | English | Compare |
Showing 1 to 2 of 2